Zurich, Switzerland; Washington, DC; and San Francisco, CA – January 5, 2010:  Next week, thousands of bio-pharma executives and investors will once again make San Francisco the nexus for life science dealmaking during four days of simultaneous industry events that include the world’s largest healthcare investor conference. During this annual biotech gathering many participants end up milling about within a few blocks of San Francisco’s Union Square, counting on chance encounters within the critical mass of executives passing between the centerpiece events being held in nearby hotels. This year EBD Group in collaboration with FierceBiotech have unveiled connectingSF™, a powerful yet simple networking tool designed to help executives make better use of their time and cut through the chaos while in San Francisco.
Once active, connectingSF participants can post profiles, send messages to other participants and search the database of the community to locate colleagues or identify potential new partners. Participants are encouraged to invite their personal contacts to join, setting off a virtuous cycle that brings more members into the community.
“We developed connectingSF to help biotech executives optimize the use of their time and maximize productivity during this critical week in our industry. connectingSF will help these people identify, communicate with- and organize meaningful meetings with targeted counterparts, rather than trusting their schedules to luck,” said Carola Schropp, President of EBD Group, the developer of the connectingSF community.
“Free to all users, connectingSF is our contribution to what has become a landmark in the life science calendar,” added Schropp. “We wanted to bring some order out of the chaos without disturbing the spontaneous spirit that builds during this exciting week.”
“FierceBiotech is the first place industry executives turn when news happens, and connectingSF is a natural extension of that mission. We want to help our busy readers spend more time networking and less time preparing for it. This simple and elegant tool does exactly that,” adds Arsalan Arif, Publisher of FierceBiotech.
The organizer of six annual international partnering conferences, EBD Group has sixteen years of experience in scheduling one-to-one meetings for the life sciences, from big pharma executives to small biotech entrepreneurs.
Visit the free connectingSF <www.connectingsf.com> to become part of the virtual community ahead of the real-time business meetings in San Francisco, January 11 to 14, 2010.

About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations, and include:

• BIO-Europe and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
• BioPharm America™, the fastest growing partnering event in North America
• EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
• BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
• ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
• Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world.
Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information visit www.ebdgroup.com

About FierceBiotech
FierceBiotech is the biotech industry's most widely read daily news publication. More than 75,000 top biotech executives rely on FierceBiotech for an insider briefing on the day’s top stories. Sign up is free at http://www.fiercebiotech.com.

About FierceMarkets
FierceMarkets, a leader in B2B e-media, provides information and marketing services in the Telecommunications, Life Sciences, Healthcare, IT, and Finance industries through its portfolio of e-mail newsletters, Web sites, webinars, and live events. Every business day, FierceMarkets' wide array of publications reaches more than 800,000 executives in over 100 countries. Current publications include: FierceBiotech; FierceBiotech Research; FierceBiotechIT; FierceBroadbandWireless; FierceCIO; FierceCIO:TechWatch; FierceContentManagement; FierceDeveloper; FierceEMR; FierceFinance; FierceFinanceIT; FierceGovernmentIT; FierceHealthcare; FierceHealthIT; FierceHealthFinance; FierceIPTV; FierceMobileContent; FierceMobileHealthcare; FierceMobileIT; FiercePharma; FiercePharma Manufacturing; FierceSarbox; FierceTelecom; FierceOnlineVideo; FierceVaccines; FierceVoIP; FierceWireless; FierceWireless:Europe; and Hospital Impact.

Contacts:
Constantine Theodoropulos
EBD Group
+1 617 401 3116
ctheodoropulos@ebdgroup.com

Arsalan Arif
Publisher, FierceBiotech
aa@fiercemarkets.com
+1 202 824 5080

 

Back to news